Transplantation of CD9+CD55low APCs from T2DM patients into mouse adipose tissue induces glucose intolerance and insulin resistance, while genetic knockout or pharmacological depletion of this subpopulation ameliorates obesity-associated metabolic dysfunction. Here, CD9 is linked to type 2 diabetes mellitus.